Zobrazeno 1 - 10
of 208
pro vyhledávání: '"Tzontcheva, A."'
Autor:
Dicpinigaitis, Peter V., Birring, Surinder S., Blaiss, Michael, McGarvey, Lorcan P., Morice, Alyn H., Pavord, Ian D., Satia, Imran, Smith, Jaclyn A., La Rosa, Carmen, Li, Qing, Nguyen, Allison Martin, Schelfhout, Jonathan, Tzontcheva, Anjela, Muccino, David
Publikováno v:
In Annals of Allergy, Asthma & Immunology January 2023 130(1):60-66
Autor:
McGarvey, Lorcan P, Birring, Surinder S, Morice, Alyn H, Dicpinigaitis, Peter V, Pavord, Ian D, Schelfhout, Jonathan, Nguyen, Allison Martin, Li, Qing, Tzontcheva, Anjela, Iskold, Beata, Green, Stuart A, Rosa, Carmen La, Muccino, David R, Smith, Jaclyn A *
Publikováno v:
In The Lancet 5-11 March 2022 399(10328):909-923
Autor:
Jaclyn A, Smith, Michael M, Kitt, Alan, Bell, Nicolas, Noulin, Anjela, Tzontcheva, Megan McGratty, Seng, Susan, Lu
Publikováno v:
Smith, J A, Kitt, M M, Bell, A, Noulin, N, Tzontcheva, A, Seng, M M & Lu, S 2022, ' Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection : A Phase 2a, Randomized, Placebo-Controlled Trial ', Pulmonary therapy, vol. 8, no. 3, pp. 297-310 . https://doi.org/10.1007/s41030-022-00193-w
INTRODUCTION: Available therapies for acute cough, a condition frequently caused by a viral upper respiratory tract infection (URTI), have shown limited evidence of efficacy. Gefapixant, a P2X3-receptor antagonist, has demonstrated efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038b3392d5b6562e2c888710db6b71b4
https://doi.org/10.1007/s41030-022-00193-w
https://doi.org/10.1007/s41030-022-00193-w
Autor:
Weinstein, Cindy L J, Sliwinska-Stanczyk, Paula, Hála, Tomas, Stanislav, Marina, Tzontcheva, Anjela, Yao, Ruji, Berd, Yuliya, Curtis, Sean P, Philip, George
Publikováno v:
Rheumatology; Nov2023, Vol. 62 Issue 11, p3601-3609, 9p
Autor:
Hastrup, Nina, Khalilieh, Sauzanne, Dale, David C., Hanson, Lars G., Magnusson, Peter, Tzontcheva, Anjela, Tseng, Jack, Huyck, Susan, Rosenberg, Elizabeth, Krogsgaard, Kim
Publikováno v:
In Cytokine April 2015 72(2):197-203
Autor:
Cindy L J Weinstein, Paula Sliwinska-Stanczyk, Tomas Hála, Marina Stanislav, Anjela Tzontcheva, Ruji Yao, Yuliya Berd, Sean P Curtis, George Philip
Publikováno v:
Rheumatology.
Objectives The GO-BACK study was designed to evaluate the efficacy and safety of golimumab (GLM) treatment withdrawal in adults with non-radiographic axial spondyloarthritis (nr-axSpA) who demonstrate inactive disease during a 10-month open-label (OL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4573b0242f55684309614d16498b9010
https://doi.org/10.1093/rheumatology/kead112
https://doi.org/10.1093/rheumatology/kead112
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lorcan P McGarvey, Surinder S Birring, Alyn H Morice, Peter V Dicpinigaitis, Ian D Pavord, Jonathan Schelfhout, Allison Martin Nguyen, Qing Li, Anjela Tzontcheva, Beata Iskold, Stuart A Green, Carmen La Rosa, David R Muccino, Jaclyn A Smith
Publikováno v:
COUGH-1 and COUGH-2 Investigators 2022, ' Efficacy and safety of gefapixant, a P2X 3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials ', The Lancet, vol. 399, no. 10328, pp. 909-923 . https://doi.org/10.1016/S0140-6736(21)02348-5
Background: Gefapixant is an oral P2X3 receptor antagonist that has previously shown efficacy and safety in refractory chronic cough and unexplained chronic cough. We therefore aim to confirm the efficacy and safety of gefapixant in participants with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::838940d35f61d2058207e771121821c3
https://pure.qub.ac.uk/en/publications/0b9c7e74-db7c-4e53-a26c-74130e9737ca
https://pure.qub.ac.uk/en/publications/0b9c7e74-db7c-4e53-a26c-74130e9737ca
Autor:
Tzontcheva Anna
Publikováno v:
Journal of Medical Biochemistry, Vol 29, Iss 4, Pp 254-264 (2010)
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms originating from endocrine cells, which are characterized by the presence of secretory granules as well as the ability to produce biogenic amines and polypeptide hormones. These tumo
Externí odkaz:
https://doaj.org/article/12988890477a41c2a851644ce39ec6d4
Autor:
Peter V. Dicpinigaitis, Surinder S. Birring, Michael Blaiss, Lorcan P. McGarvey, Alyn H. Morice, Ian D. Pavord, Imran Satia, Jaclyn A. Smith, Carmen La Rosa, Qing Li, Allison Martin Nguyen, Jonathan Schelfhout, Anjela Tzontcheva, David Muccino
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology.
The current characterization of patients with refractory or unexplained chronic cough (RCC and UCC, respectively) primarily stems from relatively small clinical studies.To report the baseline medical history and clinical characteristics of individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec3a6c11aed8b172efe916b345dcf92
https://pubmed.ncbi.nlm.nih.gov/35569802
https://pubmed.ncbi.nlm.nih.gov/35569802